Article Text
Statistics from Altmetric.com
- clinical procedures
- dermatology
- paediatric gastroenterology
- inflammatory bowel disease
- intravenous Iron therapy
A 17-year-old patient with Crohn’s disease underwent intravenous iron infusion (Ferinject [ferric carboxymaltose]) as treatment for iron deficiency anaemia (haemoglobin 103 g/L, ferritin 6 μg/L) as per the British Society of Paediatric Gastroenterology, Hepatology and Nutrition1 guidelines (20 mg/kg, maximum of 1000 mg per single dose). Pain at the cannula site was reported during the infusion, which was immediately stopped, with the cannula removed and resited to continue the infusion. Two days post-infusion a patchy, …
Footnotes
Contributors REH prepared the manuscript, with comments and review from all authors. VG, LC and RKR provided critical review of the manuscript. All authors approved the draft.
Funding REH’s Clinical Research Fellow role at the Royal Hospital for Children, Glasgow is supported by the Catherine McEwan Foundation. RKR is supported by an NHS Research Scotland senior fellowship award.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.